Mail

UK markets close in 5 hours 59 minutes

FTSE 100
8,396.18
-28.02(-0.33%)
FTSE 250
20,780.25
-93.08(-0.45%)
AIM
807.68
-2.26(-0.28%)
GBP/EUR
1.1694
-0.0004(-0.03%)
GBP/USD
1.2717
+0.0011(+0.08%)
Bitcoin GBP
55,806.27
+3,169.71(+6.02%)

What pension research reveals about retirement planning

As the cost of living crisis eases, what steps are you taking to build your pension?

Ono Pharmaceutical Co., Ltd. (4528.T)

Tokyo - Tokyo Delayed price. Currency in JPY

Add to watchlist

2,290.00

-16.00

(-0.69%)

At close: 03:15PM JST

Currency in JPY

Valuation measures⁴

Market cap (intra-day)	1.08T
Enterprise value	887.27B
Trailing P/E	8.65
Forward P/E	13.95
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	2.20
Price/book (mrq)	1.37
Enterprise value/revenue	1.77
Enterprise value/EBITDA	4.87

Trading information

Stock price history

Beta (5Y monthly)	0.20
52-week change ³	-12.73%
S&P500 52-week change ³	28.04%
52-week high ³	2,966.50
52-week low ³	2,232.50
50-day moving average ³	2,385.72
200-day moving average ³	2,595.49

Share statistics

Avg vol (3-month) ³	2.17M
Avg vol (10-day) ³	2.35M
Shares outstanding ⁵	469.65M
Implied shares outstanding ⁶	474.89M
Float ⁸	453.32M
% held by insiders ¹	15.55%
% held by institutions ¹	46.84%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	80
Forward annual dividend yield ⁴	3.47%
Trailing annual dividend rate ³	80.00
Trailing annual dividend yield ³	3.47%
5-year average dividend yield ⁴	2.04
Payout ratio ⁴	30.01%
Dividend date ³	N/A
Ex-dividend date ⁴	27 Sept 2024
Last split factor ²	5:1
Last split date ³	29 Mar 2016

Financial highlights

Fiscal year

Fiscal year ends	31 Mar 2024
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	25.46%
Operating margin (ttm)	13.58%

Management effectiveness

Return on assets (ttm)	11.13%
Return on equity (ttm)	16.56%

Income statement

Revenue (ttm)	502.67B
Revenue per share (ttm)	1,047.21
Quarterly revenue growth (yoy)	4.30%
Gross profit (ttm)	N/A
EBITDA	178.07B
Net income avi to common (ttm)	127.98B
Diluted EPS (ttm)	266.57
Quarterly earnings growth (yoy)	2.10%

Balance sheet

Total cash (mrq)	204.6B
Total cash per share (mrq)	435.64
Total debt (mrq)	8.86B
Total debt/equity (mrq)	1.11%
Current ratio (mrq)	3.99
Book value per share (mrq)	1,688.42

Cash flow statement

Operating cash flow (ttm)	110.66B
Levered free cash flow (ttm)	49.81B